Chennai Meenakshi Multispeciality Hospital share price
BSE: 523489Healthcare ServicesSmall Cap
Chennai Meenakshi Multispeciality Hospital Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1992
Last close ₹34.01down ₹1.23 (3.49%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹35.24.
28 Oct: open ₹35.00, high ₹35.00, low ₹34.00
52-week range of traded prices to 28 Oct 2026
₹31.51Low, 6 Apr 2026₹55.70High, 28 Oct 2025
- Under BSE's graded surveillance, stage 0, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹25 Cr3,848th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −6.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 543
Results
Standalone; ₹ crore.Chennai Meenakshi Multispeciality Hospital quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +6.5%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹8.59 Crdown 12.44%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- ₹0.00 CrQuarter to Mar 2026: −₹0.02 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 0.0%
Revenue by quarter
Peak revenue ₹9.81 Cr, quarter to Mar 2026; lowest ₹8.07 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
Back to profit in the quarter to Jun 2026, ₹0.00 CrA loss in 5 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.07 | 8.83 | 9.17 | 8.65 | 9.47 | 9.11 | 9.81 | 8.59 |
| Net profit | −0.67 | −0.63 | 0.31 | −0.74 | 0.15 | −0.54 | −0.02 | 0.00 |
| Net margin | −8.4% | −7.1% | 3.4% | −8.6% | 1.6% | −5.9% | −0.2% | 0.0% |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹37 Crup 6.38%
- Net profitNet profit. Under it, net profit in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹1.12 CrYear to Mar 2025: −₹1.37 Cr
- Net margin
- −3.0%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 5 of the 10 years shown
The years either side of a change of basis do not compare. From the year to Mar 2024, the company's revenue for that year, ₹38 Cr, differs from its quarters added, ₹31 Cr.
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.0 | 23.5 | 22.4 | 25.8 | 19.4 | 31.3 | 28.4 | 38.2 | 34.8 | 37.0 |
| Net profit | −0.9 | 1.5 | 0.0 | 0.5 | −1.2 | 4.0 | 0.9 | −0.4 | −1.4 | −1.1 |
| Net margin | −4.8% | 6.4% | 0.2% | 2.1% | −6.2% | 12.8% | 3.1% | −1.1% | −3.9% | −3.0% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, HEALTH CARE SERVICES, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +7.0% | – | – | 0.0% |
| 3 years | +21.2% | – | – | 0.0% |
| 5 years | +27.6% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Chennai Meenakshi Multispeciality Hospital competitors and peers
Healthcare Service Provider, 37 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Chennai Meenakshi Multispeciality Hospital in market cap. 3 companies in the table last traded before then: their rows are priced on their last trade.Healthcare companies
Chennai Meenakshi Multispeciality Hospital is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Deccan Health CareDECCAN | 29 | 11.38 | 0.26 | −0.4% | +145.9% | 2.3% | 3.3% | 0.00% |
 Samsrita LabsSAMSRITA | 27 | – | 2.32 | – | – | – | −65.3% | 0.00% |
 Sharma East India Hospitals and ResSHARMEH | 26 | 22.30 | 1.93 | +14.1% | −9.9% | 9.0% | 9.1% | 0.00% |
 Tejnaksh HealthcareTEJNAKSH | 26 | 20.48 | 0.94 | −13.0% | −37.0% | 4.7% | 5.2% | 0.00% |
 Nidan Laboratories and HealthcareNIDAN | 18 | 12.00 | 0.26 | +4.1% | −23.8% | 2.2% | – | 0.00% |
 Transgene BiotekTRABI | 18 | – | 2.13 | −15.0% | – | −17.5% | −2.6% | 0.00% |
 Dolphin Medical ServicesDOLPHMED | 10 | – | 1.02 | – | – | – | – | 0.00% |
 Family Care HospitalsFAMILYCARE | 10 | – | 1.02 | −93.9% | – | −73.4% | −27.5% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Chennai Meenakshi Multispeciality Hospital announcements
Oct 2026
26 Oct · Board meeting
Meeting on 2 Nov 2026: quarterly results15 Oct · Announcement Under Regulation 30 (LODR)-Updates(Re-Constitution Of Committees-Intimation)
Chennai Meenakshi Multispeciality Hospital annual report, year to Mar 2026
Chennai Meenakshi Multispeciality Hospital share price by year
Each calendar year to 2025.Chennai Meenakshi Multispeciality Hospital share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 45.99 | +9.5% | 55.93 | 29.36 |
| 2024 | 42.00 | +0.2% | 56.18 | 30.79 |
| 2023 | 41.92 | +83.9% | 50.10 | 18.55 |
| 2022 | 22.80 | −7.5% | 28.50 | 17.40 |
| 2021 | 24.65 | +137.2% | 29.95 | 8.92 |
| 2020 | 10.39 | +31.5% | 16.75 | 7.50 |
| 2019 | 7.90 | −37.4% | 15.65 | 4.43 |
| 2018 | 12.61 | −8.2% | 31.55 | 11.20 |
| 2017 | 13.73 | +2.1% | 17.11 | 10.60 |
| 2016 | 13.45 | −7.2% | 17.45 | 10.01 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | 35.05 | 35.25 | 33.60 | 35.24 | 34.99 | 7,972 |
| 26 Oct 2026 | 36.75 | 36.75 | 35.00 | 35.01 | 35.07 | 630 |
| 23 Oct 2026 | 37.35 | 37.35 | 36.40 | 36.40 | 37.00 | 106 |
| 22 Oct 2026 | 36.68 | 37.00 | 35.10 | 37.00 | 36.13 | 2,750 |
| 21 Oct 2026 | 38.95 | 38.95 | 37.01 | 37.89 | 37.49 | 218 |
| 19 Oct 2026 | 37.00 | 39.00 | 37.00 | 38.50 | 38.30 | 217 |
| 16 Oct 2026 | 37.39 | 37.39 | 36.78 | 36.90 | 36.88 | 452 |
| 15 Oct 2026 | 36.75 | 38.00 | 36.70 | 37.02 | 36.78 | 700 |
| 14 Oct 2026 | 41.99 | 42.00 | 36.15 | 38.97 | 39.70 | 911 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 523489
- ISIN
- INE889F01017
- Industry
- Healthcare Services
- Website
- www.cmmh.in
- CIN
- L85110TN1990PLC019545
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1990
- Registered office
- Old No. 149, New No. 70, Luz Church Road, Mylapore, Chennai 600004, Tamil Nadu
- Share registrar
- Cameo Corporate Services Ltd
- Keeps the register of shareholders and handles transfers and dividend payments